The biologically active metabolite of vitamin D 3 , 1α,25-dihydroxyvitamin D 3 [1α,25(OH) 2 D 3 ], acts through vitamin D receptors, which were found in rheumatoid tissues in the present study. IL-1β-activated rheumatoid synovial fibroblasts and human articular chondrocytes were shown to respond differently to exposure to 1α,25(OH) 2 D 3 , which has different effects on the regulatory pathways of specific matrix metalloproteinases and prostaglandin E 2 . 
Introduction: 1α,25-dihydroxyvitamin D 3 [1α,25(OH) 2 D 3 ] , the biologically active metabolite of vitamin D 3 , acts through an intracellular vitamin D receptor (VDR) and has several immunostimulatory effects. Animal studies have shown that production of some matrix metalloproteinases (MMPs) may be upregulated in rat chondrocytes by administration of 1α,25(OH) 2 D 3 ; and cell cultures have suggested that 1α,25(OH) 2 D 3 may affect chondrocytic function. Discoordinate regulation by vitamin D of MMP-1 and MMP-9 in human mononuclear phagocytes has also been reported. These data suggest that vitamin D may regulate MMP expression in tissues where VDRs are expressed. Production of 1α,25(OH) 2 D 3 within synovial fluids of arthritic joints has been shown and VDRs have been found in rheumatoid synovial tissues and at sites of cartilage erosion. The physiological function of 1α,25(OH) 2 D 3 at these sites remains obscure. MMPs play a major role in cartilage breakdown in the rheumatoid joint and are produced locally by several cell types under strict control by regulatory factors. As 1α,25(OH) 2 D 3 modulates the production of specific MMPs and is produced within the rheumatoid joint, the present study investigates its effects on MMP and prostaglandin E 2 (PGE 2 ) production in two cell types known to express chondrolytic enzymes. Aims: To investigate VDR expression in rheumatoid tissues and to examine the effects of 1α,25-dihydroxyvitamin D 3 on cultured rheumatoid synovial fibroblasts (RSFs) and human articular chondrocytes (HACs) with respect to MMP and PGE 2 production. Methods: Rheumatoid synovial tissues were obtained from arthroplasty procedures on patients with late-stage rheumatoid arthritis; normal articular cartilage was obtained from lower limb amputations. Samples were embedded in paraffin, and examined for presence of VDRs by immunolocalisation using a biotinylated antibody and alkaline-phosphatase-conjugated avidin-biotin complex system. Cultured synovial fibroblasts and chondrocytes were treated with either 1α,25(OH) 2 D 3 or interleukin (IL)-1β, or both. Conditioned medium was assayed for MMP and PGE 2 by enzyme-linked immunosorbent assay (ELISA), and the results were normalised relative to control values. Results: The rheumatoid synovial tissue specimens (n = 18) immunostained for VDRs showed positive staining but at variable distributions and in no observable pattern. VDRpositive cells were also observed in association with some cartilage-pannus junctions (the rheumatoid lesion). MMP production by RSFs in monolayer culture was not affected by treatment with 1α,25(OH) 2 D 3 alone, but when added simultaneously with IL-1β the stimulation by IL-1β was reduced from expected levels by up to 50%. In contrast, 1α,25(OH) 2 D 3 had a slight stimulatory effect on basal production of MMPs 1 and 3 by monolayer cultures of HACs, but stimulation of MMP-1 by IL-1β was not affected by the simultaneous addition of 1α,25(OH) 2 D 3 whilst MMP-3 production was enhanced ( Table 1 ). The production of PGE 2 by RSFs was unaffected by 1α,25(OH) 2 D 3 addition, but when added concomitantly with IL-1β the expected IL-1β-stimulated increase was reduced to almost basal levels. In contrast, IL-1β stimulation of PGE 2 in HACs was not affected by the simultaneous addition of 1α,25(OH) 2 [1] . It also has several immunomodulatory actions such as its effect on the differentiation and proliferation of T lymphocytes, and the regulation of immunoglobulin production by B lymphocytes [2] [3] [4] . 1α,25(OH) 2 D 3 may affect chondrocytic function, such as proteoglycan and collagen synthesis [5] ; and animal studies have shown that the production of some matrix metalloproteinases (MMPs), namely interstitial collagenase (MMP-1), stromelysin (MMP-3) and 72-kDa gelatinase (MMP-2), may be upregulated in rat chondrocytes by administration of the metabolite [6] . Discoordinate regulation by vitamin D of MMP-1 and MMP-9 in human mononuclear phagocytes has also been reported [7] . Together these data have suggested that vitamin D can regulate MMP expression in tissues or pathologies where receptors for the hormone are expressed.
The kidney is recognized as the primary source of 1α,25(OH) 2 D 3 , producing the metabolite via 1-hydroxylation of 25-hydroxyvitamin D 3 [1] . However, the local production of 1α,25(OH) 2 D 3 within synovial fluids of arthritic joints, especially the macrophage component, has recently been indicated [8, 9] ; and receptors for vitamin D have also been demonstrated in rheumatoid synovial tissues and at sites of cartilage erosion [10] . Such studies have demonstrated a local source of 1α,25(OH) 2 D 3 within the rheumatoid joint, but its regulation and physiological functions at this site remain obscure.
MMPs are reputed to play a major role in cartilage breakdown in the rheumatoid joint and are produced locally by several cell types, but especially by synovial fibroblasts and articular chondrocytes [11] [12] [13] [14] [15] [16] . MMP production and release is microenvironmental in nature and is tightly regulated by several factors, including the proinflammatory cytokines tumour necrosis factor-α and interleukin (IL)-1β [17] . Because 1α,25(OH) 2 D 3 has been shown to modulate the production of specific MMPs and is produced within the rheumatoid joint, the present study was designed to investigate the effects of 1α,25(OH) 2 D 3 on MMP and prostaglandin E 2 (PGE 2 ) production by rheumatoid synovial fibroblasts (RSFs) and human articular chondrocytes (HACs), cell types known to express chondrolytic enzymes both in vitro and in vivo.
Methods

Tissue samples
Samples of rheumatoid synovial tissue, cartilage and cartilage-pannus junction were obtained from arthroplasty procedures performed on patients with classic late-stage rheumatoid arthritis. Normal articular cartilage samples were obtained from lower limb amputations. Samples were fixed in Carnoy's fixative at 20°C for 2h, embedded in paraffin wax and 5µm sections cut. Tissue sections were dewaxed, rehydrated and examined for the presence of VDR.
Immunolocalization of vitamin D receptors
Tissue sections were treated with 2N HCl at 37°C for 30 min, this being the antigen retrieval procedure recommended by the supplier of the primary antibody. Nonimmune rabbit serum at 10% (vol : vol) in TRIS-buffered saline was applied to the sections for 20 min at 20°C before incubation with the primary antibody. Rat monoclonal antibody to chick VDR (Biogenex, San Remo, USA), which is known to cross-react with human VDR, was applied to the sections for 2 h at 20°C after dilution 1 : 40 in TRIS-buffered saline. After 3 × 10 min washing in TRIS-buffered saline, biotinylated rabbit anti-rat immunoglobulin G (DAKO, Glostrup, Denmark) diluted 1 : 200 in TRIS-buffered saline was applied to the sections for 45 min at 20°C. After further washing in TRIS-buffered saline, alkaline phosphataseconjugated ABC (Avidin-biotin complex system; DAKO) was applied to the sections for 45 min at 20°C, diluted as instructed by the supplier. After further washing the alkaline phosphatase was developed using new fuchsin substrate to give a red colour. Sections were lightly counterstained using Harris's haematoxylin or toluidine blue. Non-immune rat immunoglobulin G was substituted for the primary antibody at similar concentrations on control tissue sections [10] .
Cell cultures
Rheumatoid synovial tissue and human articular cartilage were enzymically digested to provide synovial fibroblast and chondrocyte cultures as previously described [18, 19] . Cells were grown in Dulbecco's Modified Eagle's Medium + 10% (vol : vol) foetal calf serum, harvested and seeded into 12-well culture dishes (Nunc, Gibco, UK) Triplicate wells of confluent cell cultures in Dulbecco's Modified Eagle's Medium + 2% foetal calf serum were treated with 1α,25(OH) 2 D 3 (10 -8 mol/l), IL-1β (0.05 ng/ml), or IL-1β + 1α,25(OH) 2 D 3 (0.05 ng/ml and 10 -8 mol/l, respectively) and incubated for 48 h at 37°C. The conditioned medium was collected and assayed for MMP-1, MMP-2, MMP-3 and MMP-9, and PGE 2 using enzymelinked immunosorbent assay (ELISA) methodology. Cell numbers per well were counted at the end of each experiment after 70% ethanol fixation and toluidine blue staining.
Enzyme linked immunosorbent assays
ELISA methodology was used to determine protein levels of MMP-1 (collagenase 1), MMP-3 (stromelysin) and MMP-9 (gelatinase B) as previously described [20] . MMP-2 (Gelatinase A) was measured using ELISA kits pur- 
Results
Demonstration of the vitamin D receptor in rheumatoid tissues in vivo
Specimens of rheumatoid synovial tissue (n = 18) immunostained for VDR were shown to have variable distributions of the receptor. All specimens showed some positive staining, but this could be less than 5% or as much as 70% of the total cell population. Different cell types within the synovial specimens were shown to express the receptor, including macrophages, endothelial cells, lymphocytes and fibroblastic cells, but no regular pattern was observed. Cells with fibroblastic morphology immunostained for VDR are shown in Figure 1a . Chondrocytes within articular cartilage from rheumatoid joints also expressed the receptor in six out of 10 specimens (Fig. 1b) , this being a much higher frequency compared with the one in 10 specimens of normal articular cartilage from nonarthritic joints (data not shown). VDR-positive cells were also observed in association with some cartilage-pannus junctions, described here as the rheumatoid lesion (Fig. 1c) . 
Effects of 1α α,25-dihydroxyvitamin D 3 on matrix metalloproteinase production by human articular chondrocytes
In contrast to the data for RSFs, 1α,25(OH) 2 D 3 had a slight stimulatory effect on basal production of MMP-1 and 's t-test) . When stimulated with IL-1β MMP-1 and MMP-3 production was increased, and although simultaneous addition of 1α,25(OH) 2 D 3 had no effect on the stimulation of the MMP-1 enzyme, MMP-3 production was further enhanced (Fig 3b: P = 0 .008, by Students t-test). MMP-9 and MMP-2 were not produced in measurable quantities by these HAC cultures, either with or without IL-1β stimulation.
Effects of 1α α,25-dihydroxyvitamin D 3 on prostaglandin E 2 production by rheumatoid synovial fibroblasts and human articular chondrocytes PGE 2 production by RSFs was unaffected by the addition of 1α,25(OH) 2 D 3 alone. Treatment of RSFs with IL-1β upregulated the production of PGE 2 , but the addition of 1α,25(OH) 2 D 3 together with IL-1β reduced the expected stimulation of PGE 2 almost to control values (Fig. 4a: http://arthritis-research.com/14oct99/ar0101p01 Treatment of HACs with IL-1β also increased the production of PGE 2 , but in contrast to the effects noted for RSFs this IL-1-stimulation of PGE 2 was not affected by the concomitant addition of 1α,25(OH) 2 D 3 (Fig. 4b) .
To examine the possibility that 1α,25(OH) 2 D 3 might obscure or interact with the IL-1β receptor of RSFs the latter were pretreated with 1α,25(OH) 2 D 3 before incubation with IL-1β. Figure 4c shows that a 1-h preincubation with 1α,25(OH) 2 D 3 followed by IL-1β was not significantly different from the two factors added together, but preincubation with 1α,25(OH) 2 D 3 for 16 h suppressed the expected increase in PGE 2 production to control values. This effect was noted even when the 1α,25(OH) 2 D 3 was removed after the 16 h and IL-1β then added alone (Fig.  4c, data column F) . Thus, rather than directly interfering with the IL-1β receptor, it appears that 1α,25(OH) 2 D 3 reduces the capacity of the RSFs to elaborate PGE 2 (and probably the MMPs shown in Fig. 2 ) after IL-1β induction.
Discussion
The cell types within the rheumatoid lesion which were observed to express VDR included chondrocytes, fibroblasts, macrophages, lymphocytes and endothelial cells. These cells are all purported to be involved either directly or indirectly in the degradative processes associated with rheumatoid arthritis, possibly via their MMP and prostanoid production, or via the production of mediators responsible for inflammation and induction of proteinase expression by other cell types. Thus, the demonstration of VDR within the rheumatoid lesion provides support for a functional role of 1α,25(OH) 2 D 3 in rheumatoid arthritis.
MMPs are considered to play important roles in the chondrolytic processes of the rheumatoid lesion [14, 15, 17] . These enzymes are known to be produced by both fibroblasts and chondrocytes, but little has been reported in the literature regarding a relationship between 1α,25(OH) 2 D 3 and MMP production or its regulation, and most of the data to date have been obtained from animal studies or immortalized cell lines [5] [6] [7] . 1α,25(OH) 2 D 3 had little effect on basal MMP production by RSFs and marginally increased the basal production of MMP-1 and MMP-3 by chondrocytes. More pronounced differences were noted when IL-1β-stimulated or activated cells were treated with 1α,25(OH) 2 D 3 , the RSFs and HACs showing quite disparate responses. These opposite effects may be of relevance to the processes of joint destruction, especially cartilage loss, because the ability of 1α,25(OH) 2 D 3 to potentiate MMP-1 and MMP-3 expression by 'activated' chondrocytes might facilitate intrinsic cartilage chondrolysis in vivo. By contrast, the MMP-suppressive effects observed for 1α,25(OH) 2 D 3 treatment of 'activated' synovial fibrob- 
